New PIP QI dataset provides ‘snapshot’ of general practice More than 5600 general practices took part in the program – but given the current pandemic environment, how much insight is it providing?
What to know about heart attack and stroke risks after COVID-19 A new study warns that COVID-19’s impact on blood vessels could drive a new pandemic of cardiovascular disease.
Outcomes from the new CVD risk calculator depend on integration The benefits of updated guidelines will be missed if implementation issues are not urgently addressed, a GP and CVD researcher believe.
Chronic kidney disease: A patient perspective on navigating a new diagnosis GP Dr Kate Annear speaks with Dan and Jody, who have a lived experience with chronic kidney disease. They discuss helpful resources, as well as advice for health professionals looking to make the patient journey easier.
Medical software data provides fresh insight into general practice A new report containing de-identified 2020–21 data from around 10% of Australian GPs and patients has been released.
How self-targeted immune attacks may lurk behind long COVID Researchers are closing in on the link between antiviral immunity and chronic autoimmune disease, writes immunologist Matthew Woodruff.
Statins ‘not likely to cause much muscle pain’: Study New research has challenged the widespread view of statins’ link with muscle pain, leading to calls for medication labels to be revised.
The role of clinical decision tools in chronic disease care Through RACGP Foundation-supported research, a GP academic is hoping to put an end to ‘blanket recommendations’ for chronic disease.
What is ‘tomato flu?’ And should Australians be concerned about the new respiratory virus spreading rapidly among small children in India?
CVD and diabetes rates spike post-COVID: Study The risk of contracting diabetes is especially high in the first four weeks after infection, but returns to baseline within months.